Literature DB >> 11455616

Microglia in HIV-associated neurological diseases.

J D Glass1, S L Wesselingh.   

Abstract

Human immunodeficiency virus type-1 (HIV-1) is a neurotropic virus linked to a variety of progressive neurologic disorders. This review describes our current understanding of how HIV-1 enters the nervous system and interacts with neuronal and non-neuronal cells to initiate and sustain neurologic dysfunction. The overwhelming majority of cells infected with HIV-1 in the nervous system are microglia/macrophages. Microglial/macrophage infection leads to immune dysregulation as well as production and release of cytotoxic molecules. Interaction of these infected cells with astrocytes may accelerate neurotoxic mechanisms. A hypothetical scenario for how HIV-1 infection leads to neurologic disease is presented. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11455616     DOI: 10.1002/jemt.1124

Source DB:  PubMed          Journal:  Microsc Res Tech        ISSN: 1059-910X            Impact factor:   2.769


  11 in total

Review 1.  Role of microglia in central nervous system infections.

Authors:  R Bryan Rock; Genya Gekker; Shuxian Hu; Wen S Sheng; Maxim Cheeran; James R Lokensgard; Phillip K Peterson
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

2.  The recombinant vaccinia virus gene product, B18R, neutralizes interferon alpha and alleviates histopathological complications in an HIV encephalitis mouse model.

Authors:  Cari Fritz-French; Ramzi Shawahna; Jennifer E Ward; Leonard E Maroun; William R Tyor
Journal:  J Interferon Cytokine Res       Date:  2014-02-24       Impact factor: 2.607

3.  HIV-1 Tat-induced microglial activation and neuronal damage is inhibited via CD45 modulation: A potential new treatment target for HAND.

Authors:  Jingji Jin; Lucy Lam; Edin Sadic; Frank Fernandez; Jun Tan; Brian Giunta
Journal:  Am J Transl Res       Date:  2012-07-22       Impact factor: 4.060

Review 4.  Molecular and cellular mechanisms of neuronal cell death in HIV dementia.

Authors:  W Li; D Galey; M P Mattson; A Nath
Journal:  Neurotox Res       Date:  2005-10       Impact factor: 3.911

5.  HIV-1 gp120 enhances outward potassium current via CXCR4 and cAMP-dependent protein kinase A signaling in cultured rat microglia.

Authors:  Changshui Xu; Jianuo Liu; Lina Chen; Shangdong Liang; Nobutaka Fujii; Hirokazu Tamamura; Huangui Xiong
Journal:  Glia       Date:  2011-03-24       Impact factor: 7.452

6.  Khaya grandifoliola active fraction as a source of therapeutic compounds for Alzheimer's disease treatment: In silico validation of identified compounds.

Authors:  Brice Ayissi Owona; Frederic N Njayou; Pierre Mkounga; Paul F Moundipa
Journal:  In Silico Pharmacol       Date:  2022-07-04

7.  The opioid receptor antagonist, naloxone, protects spinal motor neurons in a murine model of alphavirus encephalomyelitis.

Authors:  Natalie A Prow; David N Irani
Journal:  Exp Neurol       Date:  2007-03-23       Impact factor: 5.330

8.  Human immunodeficiency virus type-1 protein Tat induces tumor necrosis factor-alpha-mediated neurotoxicity.

Authors:  Lara Buscemi; David Ramonet; Jonathan D Geiger
Journal:  Neurobiol Dis       Date:  2007-03-20       Impact factor: 5.996

9.  Evidence of human immunodeficiency virus type 1 infection of nestin-positive neural progenitors in archival pediatric brain tissue.

Authors:  Lynnae Schwartz; Lucy Civitello; Anastasie Dunn-Pirio; Samantha Ryschkewitsch; Elizabeth Berry; Winston Cavert; Nikilyn Kinzel; Diane M P Lawrence; Rohan Hazra; Eugene O Major
Journal:  J Neurovirol       Date:  2007-06       Impact factor: 2.643

10.  Involvement of Kv1.3 and p38 MAPK signaling in HIV-1 glycoprotein 120-induced microglia neurotoxicity.

Authors:  J Liu; C Xu; L Chen; P Xu; H Xiong
Journal:  Cell Death Dis       Date:  2012-01-19       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.